Cyclic AMP, at the hub of the cystic cycle

Kidney International

Volumn 66, Issue 3, 2004, Pages 1283-1285

  Torres, Vicente E ^a,b  

^a Mayo Clinic College of Medicine ^*

^b Mayo Clinic   (United States)

Author keywords

Cyclic AMP; Kidney disease; PKA; Protein

Indexed keywords

ADENYLATE CYCLASE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL FACTOR; CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYST ACTIVATING FACTOR; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MOZAVAPTAN; PHOSPHODIESTERASE; PHOSPHODIESTERASE IV; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; UNCLASSIFIED DRUG; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

CALCIUM CELL LEVEL; CELL PROLIFERATION; DEGRADATION; EDITORIAL; GENETIC DISORDER; HUMAN; INTRACELLULAR SPACE; KIDNEY POLYCYSTIC DISEASE; MEDICAL LITERATURE; NONHUMAN; PASSIVE TRANSPORT; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; REGULATORY MECHANISM; SYNTHESIS;

EID: 4344560344     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00945.x     Document Type: Editorial

References (19)

1. BELIBI FA, REIF G, WALLACE DP, et al: Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int 66:964-973, 2004
2. GRANTHAM JJ: Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: A systems biology approach. Kidney Int 64:1157-1162, 2003
3. HANAOKA K, GUGGINO W: cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol 11:1179-1187, 2000
4. VERANI RR, SILVA FG: Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: A histochemical study. Mod Pathol 1:457-463, 1988
5. WU G, D'AGATI V, CAI Y, et al: Somatic inactivation of PKD2 results in polycystic kidney disease. Cell 93:177-188, 1998
6. TORRES VE, WANG X, QIAN Q, et al: Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nature Med 10:363-364, 2004
7. DEVUYST O, BURROW CR, SMITH BL, et al: Expression of aquaporins-1 and -2 during nephrogenesis and in autosomal dominant polycystic kidney disease. Am J Physiol 271:F169-183, 1996
8. YAMAGUCHI T, NAGAO S, KASAHARA M, et al: Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis 30:703-709, 1997
9. GATTONE VH, WANG X, HARRIS PC, et al: Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9:1323-1326, 2003
10. Marfella-SCIVITTARO C, QUINONES A, ORELLANA SA: cAMP-dependent protein kinase and proliferation differ in normal and polycystic kidney epithelia. Am J Physiol Cell Physiol 282:C693-707, 2002
11. WILSON PD, SCHRIER RW, BRECKON RD, et al: A new method for studying human polycystic kidney disease epithelia in culture. Kidney Int 30:371-378, 1986
12. YASUDA G, JEFFRIES WB: Regulation of cAMP production in initial and terminal inner medullary collecting ducts. Kidney Int 54:80-86, 1998
13. MAEDA Y, TERADA Y, NONOGUCHI H, et al: Hormone and autacoid regulation of cAMP production in rat IMCD subsegments. Am J Physiol 263:F319-F327, 1992
14. PARNELL SC, MAGENHEIMER BS, MASER RL, et al: The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Commun 251:625-631, 1998
15. HELIES-TOUSSAINT C, AARAB L, GASC J-M, et al: Cellular localization of type 5 and type 6 ACs in collecting duct and regularion of cAMP systhesis. Am J Physiol Renal Physiol 279:F185-194, 2000
16. KUSANO E, MURAYAMA N, WERNESS JL, et al: Effects of calcium on the vasopressin-sensitive cAMP metabolism in medullary tubules. Am J Physiol 249:F956-966, 1985
17. CONTI M, RICHTER W, MEHATS C, et al: Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem 278:5493-5496, 2003
18. MICHALSKI A, GRZESZCZAK W: The effect of hypervolemia on electrolyte level and and level of volume regulating hormones in patients with autosomal dominant polycystic kidney disease. Pol Arch Med Wewn 96:329-343, 1996
19. GATTONE VH, MASER RL, TIAN C, et al: Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Develop Gen 24:309-318, 1999